Genetic Factors in Migraine with Aura in Argentina: An Exploratory Case-Control Study
Abstract
abstract:Migraine is a primary headache disorder with neurovascular involvement. Migraine with aura is a subtype that accounts for approximately 15%–40% of all migraine cases. Several studies have shown that the global prevalence of migraine varies depending on the population studied. The population of Buenos Aires Province has an admixed genetic background. Several genetic association studies on migraine have been reported; however, most of them were conducted in cohorts of European ancestry, introducing a bias that overlooks global population diversity. DNA was extracted from 310 individuals (153 cases and 157 controls). Genotypes were determined using allele-specific polymerase chain reaction and polymerase chain reaction–restriction fragment length polymorphism techniques for the following polymorphisms: rs2075968 (PRDM16), rs12134493 (TSPAN2), rs10166942 (TRPM8), rs10456100 (KCNK5), rs4910165 (IRAG1), rs11031122 (MPPED2), rs11172113 (LRP1), and rs6081613 (SLC24A3). A case-control analysis was conducted using logistic regression models. All markers were in Hardy-Weinberg equilibrium in the case group. In the control group, however, rs4910165 (IRAG1) deviated from equilibrium and was therefore excluded from the association analysis (p = .0032). Although codominant and dominant models including all markers simultaneously did not yield significant results, in a single-marker analysis, a trend was suggested for the AA genotype of rs2075968 (PRDM16) under a codominant model…
How strong is the evidence?
Evidence Hub reads this as a case-control. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 310 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.